LIANYOTCPharmaceutical PreparationsFiscal year ends December 31
LianBio
Financials through Q3 FY2023, quarter ended Sep 30, 2023Last filing: 10-Q on Nov 13, 2023
$0.06+0.01 (+15.10%)
Close on Oct 19, 2026
- Market cap
- $6.29M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
LianBio has not reported a dividend
No dividend per share appears in LianBio's annual filings since fiscal 2019.